NexgenRx Dividends and Buybacks
Dividend criteria checks 2/6
NexgenRx is a dividend paying company with a current yield of 3.39%.
Key information
3.4%
Dividend yield
-0.9%
Buyback Yield
| Total Shareholder Yield | 2.5% |
| Future Dividend Yield | n/a |
| Dividend Growth | -7.4% |
| Next dividend pay date | n/a |
| Ex dividend date | n/a |
| Dividend per share | US$0.00731 |
| Payout ratio | -2,786% |
Recent dividend and buyback updates
Recent updates
Stability and Growth of Payments
Fetching dividends data
Stable Dividend: NEGX.F has been paying a dividend for less than 10 years and during this time payments have been volatile.
Growing Dividend: NEGX.F has only been paying a dividend for 3 years, and since then payments have fallen.
Dividend Yield vs Market
| NexgenRx Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (NEGX.F) | 3.4% |
| Market Bottom 25% (US) | 1.4% |
| Market Top 25% (US) | 4.3% |
| Industry Average (Insurance) | 1.6% |
| Analyst forecast (NEGX.F) (up to 3 years) | n/a |
Notable Dividend: NEGX.F's dividend (3.39%) is higher than the bottom 25% of dividend payers in the US market (1.39%).
High Dividend: NEGX.F's dividend (3.39%) is low compared to the top 25% of dividend payers in the US market (4.32%).
Earnings Payout to Shareholders
Earnings Coverage: NEGX.F is paying a dividend but the company is unprofitable.
Cash Payout to Shareholders
Cash Flow Coverage: With its reasonably low cash payout ratio (41%), NEGX.F's dividend payments are well covered by cash flows.